Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2007 (2007), Article ID 24147, 8 pages
http://dx.doi.org/10.1155/2007/24147
Research Article

Cytokine Release in HR-HPV(+) Women without and with Cervical Dysplasia (CIN II and III) or Carcinoma, Compared with HR-HPV() Controls

1Department of Obstetrics and Gynaecology, Erasmus University Medical Center, CA, Rotterdam 3000, The Netherlands
2Department of Pathology, Erasmus University Medical Center, CA, Rotterdam 3000, The Netherlands
3Department of Public Health, Erasmus University Medical Center, CA, Rotterdam 3000, The Netherlands
4Department of Pathology, Vrije Universiteit Medical Center, Amsterdam MB 1007, The Netherlands

Received 1 October 2007; Accepted 16 October 2007

Copyright © 2007 Aagje G. Bais et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. K. Kjaer, B. Chackerian, A. J. C. van den Brule et al., “High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse),” Cancer Epidemiology Biomarkers & Prevention, vol. 10, no. 2, pp. 101–106, 2001. View at Google Scholar
  2. J. M. M. Walboomers, M. V. Jacobs, M. M. Manos et al., “Human papillomavirus is a necessary cause of invasive cervical cancer worldwide,” Journal of Pathology, vol. 189, no. 1, pp. 12–19, 1999. View at Publisher · View at Google Scholar
  3. T. J. M. Helmerhorst and C. J. L. M. Meijer, “Cervical cancer should be considered as a rare complication of oncogenic HPV infection rather than a STD,” International Journal of Gynecological Cancer, vol. 12, no. 3, pp. 235–236, 2002. View at Publisher · View at Google Scholar
  4. N. Muñoz, F. X. Bosch, S. de Sanjosé et al., “Epidemiologic classification of human papillomavirus types associated with cervical cancer,” New England Journal of Medicine, vol. 348, no. 6, pp. 518–527, 2003. View at Publisher · View at Google Scholar
  5. A.-B. Moscicki, J. H. Ellenberg, S. Farhat, and J. Xu, “Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type,” Journal of Infectious Diseases, vol. 190, no. 1, pp. 37–45, 2004. View at Publisher · View at Google Scholar
  6. M. A. E. Nobbenhuis, J. M. M. Walboomers, T. J. M. Helmerhorst et al., “Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study,” The Lancet, vol. 354, no. 9172, pp. 20–25, 1999. View at Publisher · View at Google Scholar
  7. T.-C. Wu and R. J. Kurman, “Analysis of cytokine profiles in patients with human papillomavirus-associated neoplasms,” Journal of the National Cancer Institute, vol. 89, no. 3, pp. 185–187, 1997. View at Publisher · View at Google Scholar
  8. B. Spellberg and J. E. Edwards Jr., “Type 1/type 2 immunity in infectious diseases,” Clinical Infectious Diseases, vol. 32, no. 1, pp. 76–102, 2001. View at Google Scholar
  9. M. Clerici, G. M. Shearer, and E. Clerici, “Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: time to consider the TH1/TH2 paradigm,” Journal of the National Cancer Institute, vol. 90, no. 4, pp. 261–263, 1998. View at Google Scholar
  10. T. Tsukui, A. Hildesheim, M. H. Schiffman et al., “Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology,” Cancer Research, vol. 56, no. 17, pp. 3967–3974, 1996. View at Google Scholar
  11. M. Clerici, M. Merola, E. Ferrario et al., “Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection,” Journal of the National Cancer Institute, vol. 89, no. 3, pp. 245–250, 1997. View at Publisher · View at Google Scholar
  12. A. de Jong, M. I. E. van Poelgeest, J. M. van der Hulst et al., “Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6,” Cancer Research, vol. 64, no. 15, pp. 5449–5455, 2004. View at Publisher · View at Google Scholar
  13. H. J. Bontkes, T. D. de Gruijl, A. Bijl et al., “Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia,” Journal of General Virology, vol. 80, no. 9, pp. 2453–2459, 1999. View at Google Scholar
  14. B.-N. Lee, M. Follen, D.-Y. Shen et al., “Depressed type 1 cytokine synthesis by superantigen-sctivated CD4+ T cells of women with human papillomavirus-related high-grade squamous intraepithelial lesions,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 2, pp. 239–244, 2004. View at Publisher · View at Google Scholar
  15. J. C. Steele, C. H. Mann, S. Rookes et al., “T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia,” British Journal of Cancer , vol. 93, pp. 248–259, 2005. View at Publisher · View at Google Scholar
  16. D. E. Warrino, W. C. Olson, W. T. Knapp et al., “Disease-stage variance in functional CD4+ T-cell responses against novel pan-human leukocyte antigen-D region presented human papillomavirus-16 E7 epitopes,” Clinical Cancer Research, vol. 10, no. 10, pp. 3301–3308, 2004. View at Publisher · View at Google Scholar
  17. N. Jacobs, S. L. Giannini, J. Doyen et al., “Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix,” Clinical & Experimental Immunology, vol. 111, no. 1, pp. 219–224, 1998. View at Publisher · View at Google Scholar
  18. H. Mori, T. Hanabayashi, Y. Yamada, and T. Tamaya, “Decrease in interferon-γ production by peripheral blood mononuclear cells in patients with uterine cervical cancer,” Journal of Clinical Immunology, vol. 10, no. 1, pp. 45–51, 1990. View at Publisher · View at Google Scholar
  19. M. Scott, M. Nakagawa, and A.-B. Moscicki, “Cell-mediated immune response to human papillomavirus infection,” Clinical and Diagnostic Laboratory Immunology, vol. 8, no. 2, pp. 209–220, 2001. View at Publisher · View at Google Scholar
  20. A. G. Bais, I. Beckmann, J. Lindemans et al., “A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions,” Journal of Clinical Pathology, vol. 58, no. 10, pp. 1096–1100, 2005. View at Publisher · View at Google Scholar
  21. A. J. C. van den Brule, R. Pol, N. Fransen-Daalmeijer, L. M. Schouls, C. J. L. M. Meijer, and P. J. F. Snijders, “GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes,” Journal of Clinical Microbiology, vol. 40, no. 3, pp. 779–787, 2002. View at Publisher · View at Google Scholar
  22. M. V. Jacobs, P. J. F. Snijders, A. J. C. van den Brule, T. J. M. Helmerhorst, C. J. L. M. Meijer, and J. M. M. Walboomers, “A general primer GP5+/GP6+-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings,” Journal of Clinical Microbiology, vol. 35, no. 3, pp. 791–795, 1997. View at Google Scholar
  23. D. de Groote, P. F. Zangerle, Y. Gevaert et al., “Direct stimulation of cytokines (IL-1ß, TNF-a, IL-6, IL-2, IFN-? and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation,” Cytokine, vol. 4, no. 3, pp. 239–248, 1992. View at Publisher · View at Google Scholar
  24. A. M. Saunders, “Sources of physiological variation in differential leukocyte counting,” Blood Cells, vol. 11, no. 1, pp. 31–48, 1985. View at Google Scholar
  25. S. McHugh, J. Deighton, I. Rifkin, and P. Ewan, “Kinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheral blood mononuclear cells in primary culture,” European Journal of Immunology, vol. 26, no. 6, pp. 1260–1265, 1996. View at Publisher · View at Google Scholar
  26. A.-B. Moscicki, J. H. Ellenberg, P. Crowley-Nowick, T. M. Darragh, J. Xu, and S. Fahrat, “Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents,” Journal of Infectious Diseases, vol. 190, no. 8, pp. 1413–1421, 2004. View at Publisher · View at Google Scholar
  27. H.-C. Lai, C.-C. Chang, Y.-W. Lin et al., “Genetic polymorphism of the interferon-? gene in cervical carcinogenesis,” International Journal of Cancer, vol. 113, no. 5, pp. 712–718, 2005. View at Publisher · View at Google Scholar
  28. D. C. Henderson and J. J. Rippin, “Stimulus-dependent production of cytokines and pterins by peripheral blood mononuclear cells,” Immunology Letters, vol. 45, no. 1-2, pp. 29–34, 1995. View at Publisher · View at Google Scholar
  29. A. G. Östor, “Natural history of cervical intraepithelial neoplasia: a critical review,” International Journal of Gynecological Pathology, vol. 12, no. 2, pp. 186–192, 1993. View at Google Scholar